Company CTT Pharmaceutical Holdings, Inc.
Equities
CTTH
US12651E1064
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -14.29% | -11.76% | +7.14% |
2020 | CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech | CI |
2020 | CTT Pharmaceutical Holdings, Inc. Announces Management Appointments | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 69 | 08/09/14 |
Ryan Khouri
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,342,381 | 7,096,974 ( 14.68 %) | 0 | 14.68 % |
Company contact information
CTT Pharmaceutical Holdings, Inc.
3853 Northdale Boulevard Suite 268
33624, Tampa
+613-241-9959
http://www.cttpharmaceuticals.comSector
1st Jan change | Capi. | |
---|---|---|
+7.14% | 1.79M | |
+33.85% | 50.85B | |
+0.30% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.81% | 26.11B | |
-21.99% | 19.13B | |
+8.74% | 13.05B | |
+27.06% | 12.16B | |
+24.33% | 12.08B |
- Stock Market
- Equities
- CTTH Stock
- Company CTT Pharmaceutical Holdings, Inc.